1. Home
  2. News
  3. Cynata Therapeutics Limited
  4. Cynata Receives Decision to Grant a Patent in Japan
More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Cynata Receives Decision to Grant a Patent in Japan

Jan 26, 2022 at 10:46 PM EST · Issued by Cynata Therapeutics Limited

Filed with ASX · Jan 26, 2022 at 10:46 PM EST · 2 pages · English

On 6ix: 6ix.com/news/cynata-receives-decision-to-grant-a-patent-in-japan

Cynata Therapeutics Limited on 6ix

Story so far

  • Further Canadian Patent for CynataAug 31, 2021
  • Cynata Receives Notice of Allowance from US Patent OfficeAug 26, 2021
  • Notice of Allowance from Israel Patent OfficeFeb 6, 2020

Earlier from Cynata Therapeutics

  • FUJIFILM Cellular Dynamics Executes Manufacturing AgreementDec 28, 2021
  • Cynata Commences DFU Clinical TrialDec 21, 2021
  • Site Initiation Visit Completed for CYP DFU Clinical TrialNov 17, 2021
  • Cynata Receives US$5m Fujifilm FeeOct 17, 2021
  • DSMB Recommends Continuation of Cynatas MEND TrialOct 7, 2021

Later from Cynata Therapeutics

  • Notice of Allowance for Cynata Chinese PatentFeb 27, 2022
  • FDA Clears Cynata IND for Phase 2 Trial in GvHDMay 26, 2022
  • Further data supports potency of Cynata MSCsJun 13, 2022
  • Pipeline Update Following Strategic Portfolio ReviewAug 11, 2022
  • Grant Award to Fund Study of Cynata MSCs in Heart DiseaseSep 25, 2022
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer